Dr. James R. Gossage Jr., MD

Dr. Gossage practices at Wellstar MCG Health Medical Center in Augusta, Georgia, part of Wellstar Health System.

Dr. Gossage's NPI, 1295845634, was assigned on August 30, 2006. Dr. Gossage graduated from Rush Medical College in 1984. Dr. Gossage's Georgia license number on file is 038782.

Dr. Gossage's primary practice is Wellstar MCG Health Medical Center, at 1120 15th Street, Augusta, GA 30912 in Richmond County. The practice phone is (706) 721-6569.

Dr. Gossage's primary practice is Wellstar MCG Health Medical Center in Augusta, Georgia, part of Wellstar Health System. The medical group on file is Wellstar Medical Group. Dmand AI also links Dr. Gossage to 2 more group practices and clinics and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Gossage practices, 3 sites in all. Vendor and product names are available with a free account.

Pulmonary disease is Dr. Gossage's primary specialty in the NPI Registry, under taxonomy code 207RP1001X. Dr. Gossage is board certified in internal medicine by the American Board of Internal Medicine. Dmand AI has Dr. Gossage's licenses on file in 2 states: Georgia and Tennessee.

CMS data shows 57 Medicare services from Dr. Gossage across 3 procedure codes in 2024, for 52 Medicare patients. Medicare paid $4,327 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 52 Medicare patients who saw Dr. Gossage in 2024. The largest group is 75 to 84, with 23 patients. 75% of them have high blood pressure, and 71% have high cholesterol. Their average risk score is 1.83, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Gossage's median patient age at 67, with 53% women.

In 2024, Dr. Gossage wrote 432 Medicare Part D claims for 56 patients. 78% of them were for generic drugs. CMS names the drug for 373 of them, across 6 drugs with 11 or more claims each, at $36,021 in total drug cost. In 2023, CMS named 325 claims across 7 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 94 out of 100 for Dr. Gossage for performance year 2024, reported through an alternative payment model (APM). Dr. Gossage accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Gossage as offering telehealth.

Dmand AI links 28 papers to Dr. Gossage, published from 2009 to 2024. 2024 was the busiest year, with 4. The most frequent topics are Telangiectasia, Hereditary Hemorrhagic, Intracranial Arteriovenous Malformations and Activin Receptors, Type II. Dr. Gossage has published most often in Clin Nucl Med. Dr. Gossage's most frequent co-authors are Helen Joo Kim, MD, Steven W. Hetts, MD and Hanny Toban Al-Samkari, MD.

Dmand AI links Dr. Gossage to 6 clinical trials, 2 of them phase 2 studies. 2 are still active or recruiting. Conditions studied include Epistaxis, Pulmonary Arterial Hypertension and Hypertension, Pulmonary.

CMS Open Payments shows 11 general payments to Dr. Gossage from 9 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 100% of the total. Gilead Sciences, Inc. paid the most, $174.

Dmand AI lists 1 award for Dr. Gossage, most recently Regional Top Doctor in 2014.

Dr. Gossage graduated from Rush Medical College in 1984.

Dr. Gossage is in network with 14 carriers, including Aetna, United Healthcare and Cigna. PPO plans come from the most carriers, 9. Check the plan with the practice before a visit.